The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
kang gao xue ya yao yan suan an huang luo er (amosulalol hydrochloride)
Author(s): 
Pages: 360-361
Year: Issue:  6
Journal: World Clinical Drugs

Keyword:  抗高血压药山之内制药公司氨磺洛尔磺酰胺高血压模型乙基哌唑嗪普萘洛尔受体结合原发性高血压病;
Abstract: <正> 化学名 (±)5-[1-羟基-2-[[2-(邻甲氧基苯氧基)乙基-]氨基]乙基]-2-甲基苯磺酰胺盐酸盐药效分类抗高血压药开发单位 (日本)山之内制药公司上市厂商 (日本)山之内制药公司,1988年3月29日药理本品对α1、α2、β1、β2受体的亲和性之间的比约为1∶1/500~1000∶0.3∶0.3。药效为哌唑嗪的1/8~30,普萘洛尔的1/12~16。对各种高血压模型一次给药有迅速而持久的降压效果,耐受性好。
Related Articles
No related articles found